Oteseconazole, a novel orally bioavailable and selective inhibitor of fungal cytochrome P450 enzyme 51 (CYP51), has shown promising efficacy in the treatment...
11 KB (804 words) - 14:56, 16 July 2024
J02AC03 Voriconazole J02AC04 Posaconazole J02AC05 Isavuconazole J02AC06 Oteseconazole J02AX01 Flucytosine J02AX04 Caspofungin J02AX05 Micafungin J02AX06 Anidulafungin...
877 bytes (221 words) - 07:30, 31 December 2022